packageVosaroxin

vosaroxin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vosaroxin is an investigational anticancer drug studied for the treatment of acute myeloid leukemia. It remains investigational and is not approved; a marketing application in the European Union was withdrawn.

Summary written by glm-5.3-flash from Wikidata Q18395775 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vosaroxin
ATC codes:L01XX53
DrugBank:DB11999
PubChem CID:9952884
Wikidata:Q18395775
formula:C18H19N5O4S
molar mass:401.441 g/mol (PubChem CID 9952884)
logP:-0.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown